Search results for:
cytarabine liposomal-DAUNOrubicin liposomal
cytarabine liposomal-DAUNOrubicin liposomal
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Cytarabine-DAUNOrubicin |
POWDER FOR INJECTION, INTRAVENOUS |
100 mg-44 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jul. 13, 2023
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions